Related Experiment Video
Updated: Jul 19, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Renal microvascular actions of calcium antagonists
1Research Services (R151) and Nephrology Section (111C1), Veterans Administration Medical Center, Miami, FL 33125, USA.
Abstract:
Calcium antagonists elicit vasodilation by altering the function of a specific class of potential-dependent calcium channels. These agents alter renal hemodynamics in a complex manner. Studies in the isolated perfused rat kidney demonstrate that the renal vasodilatory response to calcium antagonists varies depending on the nature of the underlying renal vasoconstriction. Thus, not all renal vasoconstrictor mechanisms are sensitive to calcium antagonists. Furthermore, in the presence of agonists such as norepinephrine or angiotensin II, calcium antagonists exert a greater effect on glomerular filtration rate than on renal perfusate flow. Direct observations of the renal microvasculature suggest that this preferential augmentation of glomerular filtration rate reflects the ability of calcium antagonists to dilate preglomerular vessels while preserving efferent arteriolar tone. Thus, under identical in vitro conditions, calcium antagonists reverse afferent (preglomerular) but not efferent (postglomerular) arteriolar vasoconstriction in isolated perfused hydronephrotic kidneys. Similarly, potassium (KCl)-induced depolarization, which directly activates potential-dependent calcium channels, preferentially constricts the afferent arteriole and produces a striking decrease in glomerular filtration rate and filtration fraction. Such observations indicate that differing activating mechanisms mediate vasoconstriction within the renal microcirculation and suggest that potential-dependent calcium channels prominently contribute to afferent, but not efferent, arteriolar vasoconstriction.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Vasodilators
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
